Heart attack symptoms in women

Chest pain or discomfort has long been seen as the most common early warning sign of a heart attack. But recent research has raised questions about whether this holds true for women. A new study looked at the available evidence and concluded that chest pain is the most common sign of heart attack for most women. more  

Strengthening the tumor-fighting ability of T cells

When faced with cancer, the immune system dispatches cells, called T cells, to kill the tumor. But these killer cells often fail to completely eliminate the tumor because they’re deactivated by a distinct population of T cells known as regulatory T cells. more

Research to lead to brain tumor therapies

Unique human in vitro model (cell culture) research currently underway at the Peninsula Medical School in the South West of England is set to identify and develop therapies for the treatment of multiple tumors in the brain. more  

Study shows how ignorance can be influential

In the current issue of The RAND Journal of Economics, USC researchers provide a challenge to the classic economic model of information manipulation, in which knowing more than anybody else is the key to influence. more

NYU dental researchers find evidence of periodontal disease leading to gestational diabetes  

A study by a New York University dental research team has discovered evidence that pregnant women with periodontal (gum) disease are more likely to develop gestational diabetes mellitus than pregnant women with healthy gums. more

CSI fact catching up with fiction as chemists develop new technology  

Real-life crime scene analysis of bloodstains, fingerprints, and other evidence does not match the speed and certainty on television shows such as CSI. But thanks to advances in chemistry, fact is catching up with fiction as researchers develop faster, more sensitive forensics tools, according to an article scheduled for the March 24 issue of Chemical & Engineering News, ACS’ weekly newsmagazine. more

Promising new drug targets identified for Huntington's disease

Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease. Scientists at the University of Cambridge have identified a number of candidate drugs to investigate further which encourage cells to "eat" the malformed proteins that lead to the disease. more

© RAmEx Ars Medica,Inc. All rights reserved.

Information appearing on the Vidyya Medical News Service is not intended as a substitute for professional medical care. Seek professional medical help and follow your health care provider's advice.

Interested in subscribing to our daily e-mail newsletter? Send an email to Vidyya@Ramex.com with the word subscribe in the subject field.